Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:43 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 193–216 of 385 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Hip Arthrosis Clear all

Conditions: Osteoarthritis, Rheumatoid Arthritis, Avascular Necrosis
Interventions: Not listed
Lead sponsor: Biomet Orthopedics, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2013
U.S. locations: 4
States / cities: Beaufort, South Carolina • Greenville, South Carolina • Plano, Texas + 1 more

Conditions: Diabetes Mellitus, Steroid Diabetes, Shoulder Osteoarthritis, Knee Osteoarthritis, Adhesive Capsulitis, Hip Osteoarthritis
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 40 Years to 75 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Knee Arthropathy, Hip Arthropathy, Anxiety
Interventions: Acupuncture needles; Device
Lead sponsor: Hartford Hospital; Other
Eligibility: 18 Years to 85 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Osteoarthritis, Hip
Interventions: Hip Resurfacing, Total Hip Arthroplasty; Device
Lead sponsor: Spokane Joint Replacement Center; Other
Eligibility: 20 Years to 80 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2018
U.S. locations: 1
States / cities: Spokane, Washington

Conditions: Osteoarthritis
Interventions: Peri-Articular Injection, Epidural Patient Controlled Analgesia (Epidural PCA); Procedure
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 50 Years to 80 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteoarthritis
Interventions: Lumbar Plexus Block; Procedure
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: Not listed
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Osteoarthritis, Avascular Necrosis, Rheumatoid Arthritis
Interventions: Cormet Hip Resurfacing; Device
Lead sponsor: Corin; Industry
Eligibility: Not listed
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 6
States / cities: Washington D.C., District of Columbia • Tampa, Florida • Baltimore, Maryland + 3 more

Conditions: Patellofemoral Pain Syndrome
Interventions: Lumbopelvic Manipulation, Passive lumbar spine flexion and extension; Other
Lead sponsor: Texas Woman's University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Osteoarthritis
Interventions: OA-PCP Intervention, Attention Control; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 65 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip, Osteoarthritis, Shoulder
Interventions: Liposomal bupivacaine, Standard of care analgesia; Drug
Lead sponsor: OhioHealth; Other
Eligibility: 18 Years and older
Enrollment: 211 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Hip Osteoarthritis, Arthroplasty, Replacement, Hip
Interventions: Not listed
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 18 Years and older
Enrollment: 405 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 1
States / cities: New York, New York

Conditions: Non-inflammatory Degenerative Joint Disease
Interventions: Total Hip Replacement; Procedure
Lead sponsor: Anderson Orthopaedic Research Institute; Other
Eligibility: 40 Years to 80 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2013
U.S. locations: 1
States / cities: Alexandria, Virginia

Conditions: Non-inflammatory Degenerative Joint Disease (NIDJD), Avascular Necrosis, Protrusio Acetabuli, Traumatic Arthritis, Slipped Capital Femoral Epiphyses, Fracture of the Pelvis, Diastrophic Variant, Osteoarthritis, Fused Hip
Interventions: Total Hip Arthroplasty with Longevity IT Oblique Liners, Total Hip Arthroplasty with Longevity IT Offset Liners; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Degenerative Joint Disease
Interventions: L2 paravertebral block, periarticular injection group; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 80 Years
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Osteoarthritis (OA) of the Hip, Avascular Necrosis of Bone of Hip, Protrusio Acetabuli, Traumatic Arthropathy-Hip, Slipped Capital Femoral Epiphyses, Fused Hip, Fracture of Pelvis, Diastrophic Variant
Interventions: Vivacit-E Elevated Liners; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: South Bend, Indiana

Conditions: Osteoarthritis
Interventions: Acetaminophen; Drug
Lead sponsor: Duke University; Other
Eligibility: 30 Years to 75 Years
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Femoroacetabular Impingement
Interventions: Arthroscopic Surgery, Physical Therapy; Procedure
Lead sponsor: Madigan Army Medical Center; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Tacoma, Washington

Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip
Interventions: Radiofrequency Ablation (RFA), Perineural Steroid Injection; Procedure
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 100 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Osteoarthritis of the Knee or Hip
Interventions: Fasinumab, Placebo; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 5,331 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 50
States / cities: Birmingham, Alabama • Chandler, Arizona • Glendale, Arizona + 44 more

Conditions: Non-inflammatory Joint Disease, Osteoarthritis, Avascular Necrosis, Congenital Hip Dysplasia, Post-traumatic Arthritis
Interventions: Total hip replacement/arthroplasty; Device
Lead sponsor: DePuy Orthopaedics; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2014
U.S. locations: 6
States / cities: Atlanta, Georgia • Springfield, Illinois • Cleveland, Ohio + 2 more

Conditions: Osteoarthritis, Pain
Interventions: Placebo, Fulranumab 1 mg, Fulranumab 3 mg, Opioid; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 36
States / cities: Birmingham, Alabama • Huntsville, Alabama • Cerritos, California + 33 more

Conditions: Osteoarthritis, Avascular Necrosis, Rheumatoid Arthritis
Interventions: Not listed
Lead sponsor: Zimmer Biomet; Industry
Eligibility: Not listed
Enrollment: 149 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2016
U.S. locations: 5
States / cities: Rockville, Maryland • Lima, Ohio • West Chester, Ohio + 2 more

Conditions: Arthritis
Interventions: 3D imaging & surrogate bone model; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Osteoarthritis, Arthritis
Interventions: NSAID, tanezumab; Drug · Biological
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 2,720 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 250
States / cities: Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 161 more

Search by objective public record fields.

A Clinical Investigation of the Taperloc® Microplasty™ Hip System

Effect of Corticosteroid Injections on Blood Glucose

Preoperative Acupuncture for Total Knee or Hip Arthroplasty

Dual Energy X-ray Absorptiometry (DXA) Comparison Hip Resurfacing Versus Total Hip Arthroplasty (THA)

Analgesia After Total Hip Arthroplasty: Peri-Articular Injection Versus Epidural Patient Controlled Analgesia (PCA)

Comparison of Anesthetic Techniques on Total Hip Arthroplasty

Cormet Post-PMA Study: New Enrollment

Effect of Lower Back Treatment in People With Patellofemoral Pain Syndrome.

Physical Activity Pathway for Patients With Osteoarthritis in Primary Care (OA-PCP) (R33)

Liposomal Bupivacaine Versus Standard Analgesia in Total Joint Arthroplasty (TJA)

Expectations, Satisfaction and Quality of Life in Total Hip Arthroplasty

Metal Ion Release From an FDA-Approved Metal-on-Metal Total Hip Replacement Implant

MDR - Longevity IT Oblique and Offset Liners

Study Comparing Regional Anesthetic Blocks and Periarticular Infiltration for the Management of Post-operative Pain After Direct Anterior Total Hip Arthroplasty

MDR Vivacit-E Elevated Study

Time of Intravenous Acetaminophen Administration

A Physical Therapy Program Versus Surgery for Femoroacetabular Impingement: Randomized Clinical Trial

Radiofrequency Ablation and Steroid Versus Steroid Alone for Relief of Pain in Patients With Advanced Knee and Hip Osteoarthritis

Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip

Post-approval Study of the DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis System

Study of Efficacy, Safety of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3001

A Clinical Investigation of ArComXL® Polyethylene in Total Hip Replacement

Real Time 3D Imaging and Surrogate Bone Model

Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip